Proshares Trust (ZBIO) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to -$476.9 million.
- Zenas BioPharma's Enterprise Value fell 3243.08% to -$476.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$476.9 million, marking a year-over-year decrease of 3243.08%. This contributed to the annual value of -$350.8 million for FY2024, which is 51692.67% down from last year.
- According to the latest figures from Q3 2025, Zenas BioPharma's Enterprise Value is -$476.9 million, which was down 3243.08% from -$504.2 million recorded in Q2 2025.
- Over the past 5 years, Zenas BioPharma's Enterprise Value peaked at -$37.2 million during Q1 2024, and registered a low of -$504.2 million during Q2 2025.
- Moreover, its 3-year median value for Enterprise Value was -$350.8 million (2024), whereas its average is -$274.7 million.
- Data for Zenas BioPharma's Enterprise Value shows a peak YoY increase of 3243.08% (in 2025) and a maximum YoY decrease of 105473.95% (in 2025) over the last 5 years.
- Quarter analysis of 3 years shows Zenas BioPharma's Enterprise Value stood at -$56.9 million in 2023, then crashed by 516.93% to -$350.8 million in 2024, then plummeted by 35.97% to -$476.9 million in 2025.
- Its last three reported values are -$476.9 million in Q3 2025, -$504.2 million for Q2 2025, and -$430.0 million during Q1 2025.